Iodine- and indium(III) chloride-catalyzed facile syntheses of 1,5- and 1,8-naphthyridines

Synthetic Communications

Volumn 41, Issue 12, 2011, Pages 1843-1851

  Chunavala, Kaushik C ^a   Adimurthy, Subbarayappa ^a  

^a CSIR CENTRAL SALT AND MARINE CHEMICALS RESEARCH INSTITUTE   (India)

Author keywords

Amino pyridines; Ethylacetoacetate; Glycerol; Naphthyridines

Indexed keywords

1,8 NAPHTHYRIDINE DERIVATIVE; 2 AMINOPYRIDINE; 3 AMINOPYRIDINE; INDIUM CHLORIDE IN 111;

ARTICLE; CATALYSIS;

EID: 79955698110     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397911.2010.493261     Document Type: Article

References (32)

1. (a) Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39, 2887-2893; (Pubitemid 26251026)
2. (b) Waterbeemd, H.; Smith, D. A.; Beaumont, K.; Walker, D. K. Property-based design: Optimization of drug absorption and pharmacokinetics. J. Med. Chem. 2001, 44, 1313-1333. (Pubitemid 32852106)
3. (a) Allott, C. P.; Bradbury, R. H.; Dennis, M.; Fisher, E.; Luke, R. W. A.; Major, J. S.; Oldham, A. A.; Pearce, R. J.; Reid, A. C.; Roberts, D. A.; Rudge, D. A.; Russell, S. T. Quinoline, 1,5-naphthyridine and pyridine derivatives as potent, nonpeptidic angiotensin II receptor antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 899-904; (Pubitemid 23149581)
4. (b) Norman, M. H.; Smith, H. D.; Andrews, C. W.; Tang, F. L. M.; Cowan, C. L.; Steffen, R. P. 4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists. J. Med. Chem. 1995, 38, 4670-4678;
5. (c) Takeuchi, I.; Hamada, Y. Syntheses of nitrogencontaining heterocyclic compounds, XXIII: Reaction of naphthyridine derivatives, with special reference to that of 1,7-naphthyridine. Chem. Pharm. Bull. 1976, 24, 1813-1821;
6. (d) Bisagni, E.; Landmass, C.; Thirot, S.; Huel, C. A convenient way to dibenzo[c,h]-1,5-naphthyridines (11-aza-benzo[c] phenanthridines). Tetrahedron 1996, 52, 10427-10440; (Pubitemid 26244734)
7. (e) Viti, G.; Giannotti, D.; Nannicini, R.; Balacco, G.; Pestellini, V. Synthesis of a benzo[b]-1,5-naphthyridine derivative as a potential constrained NK1 receptor antagonist. Tetrahedron Lett. 1994, 35 (32), 5939-5942. (Pubitemid 24261720)
8. Boros, E. E.; Edwards, C. E.; Foster, S. A.; Fuji, M.; Fujiwara, T.; Garvey, E. P.; Golden, P. L.; Hazen, R. J.; Jeffrey, J. L.; Johns, B. A.; Kawasuji, T.; Kiyama, R.; Koble, C. S.; Kurose, N.; Miller, W. H.;Mote, A. L.; Murai, H.; Sato, A.; Thompson, J. B.; Woodward, M. C.; Yoshinaga, T. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors. J. Med. Chem. 2009, 52, 2754-2761.
9. (a) Gellibert, F.; Woolven, J.; Fouchet, M.-H.; Mathews, N.; Goodland, H.; Lovegrove, V.; Laroze, A.; Nguyen, V.-L.; Sautet, S.; Wang, R.; Janson, C.; Smith, W.; Krysa, G.; Boullay, V.; Gouville, A.-C.; Huet, S.; Hartley, D. Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-b type I receptor inhibitors. J. Med. Chem. 2004, 47, 4494-4506; (Pubitemid 39096837)
10. (b) Zhu, S.; Zhang, Q.; Gudise, C.; Meng, L.; Wei, L.; Smith, E.; Kong, Y. Synthesis and evaluation of naphthyridine compounds as antimalarial agents. Bioorg. Med. Chem. Lett. 2007, 17, 6101-6106; (Pubitemid 47552845)
11. (c) Roma, G.; Grossi, G.; Di Braccio, M.; Piras, D.; Ballabeni, V.; Tognolini, M.; Bertoni, S.; Barocelli, E. 1,8-Naphthyridines, VII: New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. Eur. J. Med. Chem. 2008, 43, 1665-1680;
12. (d) Ghosh, K.; Sena, T.; Frohlich, R. A naphthyridine-based receptor for sensing citric acid. Tetrahedron Lett. 2007, 48, 2935-2938; (Pubitemid 46436060)
13. (e) Mogilaiah, K.; Vidya, K.; Kavitha, S.; Kumar, K. S. A naphthyridine-based receptor for sensing citric acid. Indian J. Chem. 2009, 48B, 282-285;
14. (f) Feng, W.; Satyanarayana, M.; Cheng, L.; Liu, A.; Tsai, Y-C.; Liu, L. F.; LaVoie, E. J. Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c, h][1,6]-naphthyridines as novel topoisomerase I-targeting antitumor agents. Bioorg. Med. Chem. 2008, 16, 9295-9301;
15. (g) Fine, S. A.; Heindel, N. D. Synthesis and antimalarial activity of 4-aminobenzo[b]-l,5-naphthyridine. J. Med. Chem. 1970, 13, 760-762.
16. (a) Zhu, S.; Moreno, K. X.; Jenkins, R. M.; Walmsley, J. A. Interactions of 1,5-naphthyridine with Pd(en)Cl2 or [Pd(en)(H2O)2](NO3)2 in aqueous solution. Dalton Trans. 2008, 6401-6408;
17. (b) Singh, A. N.; Thummel, R. P. 1,5-Naphthyridine as a new linker for the construction of bridging ligands and their corresponding Ru(II) complexes. Inorg. Chem. 2009, 48, 6459-6408;
18. (c) Kimura, M.; Tanaka, K. Synthesis and electrochemical reduction of a ruthenium complex bearing an N,N-bis[(benzo[g][1,5]naphthyridin-2-yl)methyl] propane-2-amine ligand as an NAD+/NADH-type redox site. Angew. Chem. Int. Ed. 2008, 47, 9768-9771.
19. 3 (tris(8-hydroxyquinolate)aluminum) and their versatile applications for organic light-emitting diodes. J. Am. Chem. Soc. 2009, 131, 763-777.
20. Adimurthy, S.; Malakar, C. C.; Beifuss, U. The influence of bases and ligands on the outcome of the Cu(I)-catalyzed oxidative homocoupling of terminal alkynes to 1,4-disubstituted 1,3-diynes using oxygen as an oxidant. J. Org. Chem. 2009, 74, 5648-5651.
21. (a) Hauser, C. R.; Reynolds, G. A. Relative ease of cyclization of 2-, 3-, and 4-aminopyridine derivatives: Synthesis of naphthyridines. J. Org. Chem. 1950, 15, 1224-1232;
22. (b) Hart, E. P. Naphthyridines, Part I: The chemistry of 1,5-naphthyridine. J. Chem. Soc., 1954, 1879-1882;
23. (c) Albert, A. Naphthyridines: Ionization constants and hpectra of four parent substances. J. Chem. Soc. 1960, 1790-1793;
24. (d) Rapoyort, H.; Batcho, A. D. 1,5-Naphthyridine and some of its alkyl derivatives. J. Org. Chem. 1963, 28, 1753-1759;
25. (e) Paudler, W. W.; Kress, T. J. Ten p-electron nitrogen heterocyclic compounds, IX: The syntheses and nuclear magnetic resonance spectra of some methylnaphthyridines. J. Org. Chem. 1966, 31, 3055-3057;
26. (f) Paudler, W. W.; Kress, T. J. Naphthyridine chemistry, V: One-step synthesis of 1,8-naphthyridines. J. Org. Chem. 1967, 32, 832-833;
27. (g) Armarego, W. L. F. Naphthyridines, part-III: Tetrahydro- and decahydro-l,5-,-1.6-,-1.7-, and -1.8-naphthyridines. J. Chem. Soc. 1967, 377-383;
28. (h) Hamada, Y.; Takeuchi, I. Synthesis of nitrogen containing compounds, XVIII: Synthesis of naphthyridine by improved one step process. Chem. Pharm. Bull. 1971, 19, 1857-1862.
29. (a) Santos, A. G. O.; Klute, W.; Torode, J.; Bohm, V. P. W.; Cabrita, E.; Runsink, J.; Hoffmann, R. W. Flexible molecules with defined shape, X: Synthesis and conformational study of 1,5-diaza-cis-decalin. New J. Chem. 1998, 993-997; (Pubitemid 128704503)
30. (b) Li, X.; Schenkel, L. B.; Kozlowski, M. C. Synthesis and resolution of a novel chiral diamine ligand and application to asymmetric lithiation-substitution. Org. Lett. 2000, 2, 875-878.
31. Unlike quinoline synthesis by catalytic methods [(a) Sridharan, V.; Ribelles, P.; Ramos, M. T.; Menendez, J. C. Cerium(IV) ammonium nitrate is an excellent, general catalyst for the Friedlander and Friedlander-Borsche quinoline syntheses: Very efficient access to the antitumor alkaloid luotonin A. J. Org. Chem. 2009, 74, 5715-5718;
32. (b) Zhang, X. L.; Wang, Q. Y.; Sheng, S. R.; Wang, Q. Liu, X. L. Efficient Friedlä nder synthesis of quinoline derivatives from 2-aminoarylketones and carbonyl compounds mediated by recyclable PEG-supported sulfonic acid. Synth. Commun. 2009, 39, 3293-3304,] naphthyridine synthesis is not explored.